Newsfeeds - Spark Newswire

1 minute read

CTS Q4 EPS $0.56 Misses $0.58 Estimate, Sales $142.28M Miss $148.17M Estimate

Today, 7:14 AM

CTS (NYSE:CTS) reported quarterly earnings of $0.56 per share which missed the analyst consensus estimate of $0.58 by 3.45 percent. This is a 14.29 percent increase over earnings of $0.49 per share from the same period

CTS

1 minute read

Reported Late Thursday Feb 9, CTS Corporation Approves New Share Buyback Program That Authorizes The Company To Repurchase Up To $50M Of Its Common Stock, Replacing The Program Authorized By The Board Of Directors In May 2021

By Happy Mohamed

Today, 7:14 AM

The Board of Directors of CTS Corporation (NYSE:CTS) approved a new share repurchase program that authorizes the company to repurchase up to $50 million of its common stock, replacing the program authorized by

CTS

9 minute read

Earnings

Earnings Scheduled For February 7, 2023

By Benzinga Insights

Today, 7:14 AM

Companies Reporting Before The Bell • BP (NYSE:BP) is likely to report quarterly earnings at $1.67 per share on revenue of $53.79 billion.

AAT

1 minute read

Jefferies Initiates Coverage On CTS with Hold Rating, Announces Price Target of $44

By Benzinga Newsdesk

Today, 7:14 AM

Jefferies analyst David Kelley initiates coverage on CTS (NYSE:CTS) with a Hold rating and announces Price Target of $44.

CTS

21 minute read

Earnings

Earnings Scheduled For November 8, 2022

By Benzinga Insights

Today, 7:14 AM

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.

ABCL

2 minute read

Boeing, Seagate, Chipotle And Other Big Losers From Wednesday

By Lisa Levin

Today, 7:14 AM

U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping over 200 points. Here is the list of some big stocks recording losses in the previous session.

AIZ

5 minute read

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:14 AM

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.

$APE